Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6104780, 11 pages
http://dx.doi.org/10.1155/2016/6104780
Research Article

Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke

1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan
2Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan
3Department of Radiology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
4Japanese Red Cross, Hokkaido Block Blood Center, Sapporo, Japan

Received 5 August 2016; Revised 16 September 2016; Accepted 29 September 2016

Academic Editor: Andrea Ballini

Copyright © 2016 Chengbo Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Shichinohe, C. Tan, T. Abumiya et al., “Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia,” Brain Research, vol. 1602, pp. 53–61, 2015. View at Publisher · View at Google Scholar
  2. H. Shichinohe and K. Houkin, “Cell therapy for stroke: review of previous clinical trials and introduction of our new trials,” Neurologia Medico-Chirurgica, vol. 56, no. 10, pp. 592–596, 2016. View at Publisher · View at Google Scholar
  3. S. A. Azizi, D. Stokes, B. J. Augelli, C. DiGirolamo, and D. J. Prockop, “Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3908–3913, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Chopp and Y. Li, “Treatment of neural injury with marrow stromal cells,” The Lancet Neurology, vol. 1, no. 2, pp. 92–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Y. Bang, J. S. Lee, P. H. Lee, and G. Lee, “Autologous mesenchymal stem cell transplantation in stroke patients,” Annals of Neurology, vol. 57, no. 6, pp. 874–882, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kuroda, H. Shichinohe, K. Houkin, and Y. Iwasaki, “Autologous bone marrow stromal cell transplantation for central nervous system disorders—recent progress and perspective for clinical application,” Journal of Stem Cells and Regenerative Medicine, vol. 7, no. 1, pp. 2–13, 2011. View at Google Scholar · View at Scopus
  7. C. Tan, H. Shichinohe, T. Abumiya et al., “Short-, middle- and long-term safety of superparamagnetic iron oxide-labeled allogeneic bone marrow stromal cell transplantation in rat model of lacunar infarction,” Neuropathology, vol. 35, no. 3, pp. 197–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Shichinohe, T. Ishihara, K. Takahashi et al., “Bone marrow stromal cells rescue ischemic brain by trophic effects and phenotypic change toward neural cells,” Neurorehabilitation and Neural Repair, vol. 29, no. 1, pp. 80–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Sugiyama, S. Kuroda, T. Osanai et al., “Near-infrared fluorescence labeling allows non-invasive tracking of bone marrow stromal cells transplanted into rat infarct brain,” Neurosurgery, vol. 68, pp. 1036–1047, 2011. View at Google Scholar
  10. M. Ito, H. Shichinohe, K. Houkin, and S. Kuroda, “Application of cell sheet technology to bone marrow stromal cell transplantation for rat brain infarct,” Journal of Tissue Engineering and Regenerative Medicine, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Fekete, M. Gadelorge, D. Fürst et al., “Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components,” Cytotherapy, vol. 14, no. 5, pp. 540–554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail, “Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells,” STEM CELLS, vol. 24, no. 2, pp. 462–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Shichinohe, S. Kuroda, K. Kudo et al., “Visualization of the Superparamagnetic Iron Oxide (SPIO)-labeled bone marrow stromal cells using a 3.0-T MRI-a pilot study for clinical testing of neurotransplantation,” Translational Stroke Research, vol. 3, no. 1, pp. 99–106, 2012. View at Publisher · View at Google Scholar
  14. F. Mannello and G. A. Tonti, “Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!,” Stem Cells, vol. 25, no. 7, pp. 1603–1609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Reinhardt, A. Stühler, and J. Blümel, “Safety of bovine sera for production of mesenchymal stem cells for therapeutic use,” Human Gene Therapy, vol. 22, no. 6, pp. 775–776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Sensebé, P. Bourin, and K. Tarte, “Good manufacturing practices production of mesenchymal stem/stromal cells,” Human Gene Therapy, vol. 22, no. 1, pp. 19–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Shichinohe, S. Kuroda, T. Sugiyama et al., “Biological features of human bone marrow stromal cells (hBMSC) cultured with animal protein-free medium-safety and efficacy of clinical use for neurotransplantation,” Translational Stroke Research, vol. 2, no. 3, pp. 307–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Horn, G. Bokermann, D. Cholewa et al., “Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells,” Cytotherapy, vol. 12, no. 7, pp. 888–898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Heiskanen, T. Satomaa, S. Tiitinen et al., “N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible,” STEM CELLS, vol. 25, no. 1, pp. 197–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sundin, O. Ringdén, B. Sundberg, S. Nava, C. Götherström, and K. Le Blanc, “No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients,” Haematologica, vol. 92, no. 9, pp. 1208–1215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Burnouf, D. Strunk, M. B. Koh, and K. Schallmoser, “Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?” Biomaterials, vol. 76, pp. 371–387, 2016. View at Publisher · View at Google Scholar
  22. K. Plöderl, C. Strasser, S. Hennerbichler, A. Peterbauer-Scherb, and C. Gabriel, “Development and validation of a production process of platelet lysate for autologous use,” Platelets, vol. 22, no. 3, pp. 204–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yamauchi, H. Saito, M. Ito, H. Shichinohe, K. Houkin, and S. Kuroda, “Platelet lysate and granulocyte-colony stimulating factor serve safe and accelerated expansion of human bone marrow stromal cells for stroke therapy,” Translational Stroke Research, vol. 5, no. 6, pp. 701–710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Bernardo, M. A. Avanzini, C. Perotti et al., “Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 121–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. L. Eppley, J. E. Woodell, and J. Higgins, “Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing,” Plastic and Reconstructive Surgery, vol. 114, no. 6, pp. 1502–1508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Doucet, I. Ernou, Y. Zhang et al., “Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications,” Journal of Cellular Physiology, vol. 205, no. 2, pp. 228–236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Sugiyama, S. Kuroda, Y. Takeda et al., “Therapeutic impact of human bone marrow stromal cells expanded by animal serum–free medium for cerebral infarct in rats,” Neurosurgery, vol. 68, no. 6, pp. 1733–1742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Shichinohe, T. Yamauchi, H. Saito, K. Houkin, and S. Kuroda, “Bone marrow stromal cell transplantation enhances recovery of motor function after lacunar stroke in rats,” Acta Neurobiologiae Experimentalis, vol. 73, no. 3, pp. 354–363, 2013. View at Google Scholar · View at Scopus
  29. J. Donovan, D. Abraham, and J. Norman, “Platelet-derived growth factor signaling in mesenchymal cells,” Frontiers in Bioscience, vol. 18, no. 1, pp. 106–119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Kikuchi, Y. Soma, M. Fujimoto et al., “Dermatofibrosarcoma protuberans: increased growth response to platelet-derived growth factor BB in cell culture,” Biochemical and Biophysical Research Communications, vol. 196, no. 1, pp. 409–415, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. H. S. Cho, I. H. Song, S.-Y. Park, M. C. Sung, M.-W. Ahn, and K. E. Song, “Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells,” The Korean Journal of Laboratory Medicine, vol. 31, no. 3, pp. 212–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Devescovi, E. Leonardi, G. Ciapetti, and E. Cenni, “Growth factors in bone repair,” La Chirurgia degli Organi di Movimento, vol. 92, no. 3, pp. 161–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Fukiage, T. Aoyama, K. R. Shibata et al., “Expression of vascular cell adhesion molecule-1 indicates the differentiation potential of human bone marrow stromal cells,” Biochemical and Biophysical Research Communications, vol. 365, no. 3, pp. 406–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. B. Adesida, A. Mulet-Sierra, and N. M. Jomha, “Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells,” Stem Cell Research & Therapy, vol. 3, no. 2, article 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus